- BCRX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $12.8 million.
- BCRX has traded 83,986 shares today.
- BCRX is down 3.2% today.
- BCRX was up 6.9% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in BCRX with the Ticky from Trade-Ideas. See the FREE profile for BCRX NOW at Trade-Ideas More details on BCRX: BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. Currently there are 8 analysts that rate Biocryst Pharmaceuticals a buy, 1 analyst rates it a sell, and 1 rates it a hold. The average volume for Biocryst Pharmaceuticals has been 1.3 million shares per day over the past 30 days. Biocryst has a market cap of $799.8 million and is part of the health care sector and drugs industry. The stock has a beta of 4.96 and a short float of 19.7% with 9.09 days to cover. Shares are up 45.7% year-to-date as of the close of trading on Tuesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.